Patient Survival and Factors Affecting Mortality on Automated Peritoneal Dialysis in Phra Nakhon Si Ayutthaya Hospital

Authors

  • Saowalak Chowpontong Department of Internal Medicine, Phra Nakhon Si Ayutthaya Hospital

Keywords:

survival rate, automated peritoneal dialysis, COVID-19, dialysis adequacy

Abstract

Objective: To study the survival rate and factors affecting mortality in end-stage renal disease patients undergoing automated peritoneal dialysis under the universal coverage scheme treated at Phra Nakhon Si Ayutthaya Hospital during June 1st2021 – 30thJune 2023. Methods: This was a retrospective cohort study by reviewing electronic medical records. Data was collected from end-stage renal disease patients on continuous ambulatory peritoneal dialysis (CAPD) who met the criteria for switching to APD treatment. Patients were then trained to use the automated peritoneal dialysis machine. Treatment was adjusted by determining dialysate volume and dwell cycles to achieve adequate peritoneal dialysis targets of weekly KT/V urea ≥1.7, CCr >45L/week/1.73 m2, and mean ultrafiltration >0.75L/day. Patient data and laboratory results were collected and analyzed statistically to determine survival rates and factors affecting mortality during June 1st2021 - 30thJune 2023. Results: There were 58 patients with a mean age of 56 years, predominantly female (51.7%). The causes of renal failure were diabetes mellitus 58.62%, unknown 18.96%, glomerulonephritis 10.34%. There were 3 HIV-positive patients and 1 pure red cell aplasia patient. The mean albumin was 3.36 ± 0.051 g/dL. Thirty-six percent were anuric patients. Follow-up showed 59.6% achieved weekly KT/V urea ≥1.7, mean CCr 42.5 ± 3.2 L/week/1.73 m2, mean ultrafiltration 0.78 ± 0.29 L/day. During the study period, 26 patients discontinued APD treatment, with 15 deaths (25.86%). The leading cause of death was cardiovascular disease (46.66%), followed by COVID-19 pneumonia (13.33%), and PD-related peritonitis (6.66%). Nine patients (15.51%) transitioned to hemodialysis. The 1-year and 2-year survival rates of APD patients at Phra Nakhon Si Ayutthaya Hospital were 68.8% and 59%, respectively. Conclusion: The 1-year and 2-year survival rates of APD patients at Phra Nakhon Si Ayutthaya Hospital during June 2021 - June 2023 were 68.8% and 59%, respectively. After controlling for other factors, patients with weekly KT/V urea <1.7 had a 3.37 times higher risk of mortality compared to those with weekly KT/V urea ≥1.7. Patients with treatment-resistant peritonitis had a 16.67 times higher risk of mortality compared to those without treatment-resistant peritonitis.

References

คณะอนุกรรมการลงทะเบียนการรักษาทดแทนไต สมาคมโรคไตแห่งประเทศไทย. ข้อมูลการบำบัดทดแทนไตในประเทศไทย พ.ศ. 2559-2562 [อินเทอร์เน็ต]. 2563 [เข้าถึงเมื่อ 1 ก.ค. 2566]. เข้าถึงได้จาก: https://www.nephrothai.org/wp-content/uploads/2021/01/1.TRT-Annual-report-2016-2019.pdf

Fenton SS, Schaubel DE, Desmeules M, Morrison HI, Mao Y, Copleston P, et al. Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis 1997;30(3):334-42.

Al Sahlawi M, Zhao J, McCullough K, Fuller DS, Boudville N, Ito Y, et al. Variation in peritoneal dialysis-related peritonitis outcomes in the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS). Am J Kidney Dis 2022;79(1):45–55.

Bro S, Bjorner JB, Tofte-Jensen P, Klem S, Almtoft B, Danielsen H, et al. A prospective, randomized multicenter study comparing APD and CAPD treatment. Perit Dial Int 1999;19(6):526-33.

de Fijter CW, Oe LP, Nauta JJ, van der MJ, Verbrugh HA, Verhoef J, et al. Clinical efficacy and morbidity associated with continuous cyclic compared with continuous ambulatory peritoneal dialysis. Ann Intern Med 1994;120(4):264-71.

Iles-Smith H, Curwell J, Gokal R: Comparative evaluation of CAPD and PD-plus effectiveness. EDTNA ERCA J 1999;25(3):27-9.

Sun CY, Lee CC, Lin YY, Wu MS. In younger dialysis patients, automated peritoneal dialysis is associated with better long-term patient and technique survival than is continuous ambulatory peritoneal dialysis. Perit Dial Int 2011;31(3):301-7.

Pérez Fontán M, Remón Rodríguez C, Borràs Sans M, Sanchez Alvarez E, da Cunha Naveira M, Quiros Ganga P, et al. Compared decline of residual kidney function in patients treated with automated peritoneal dialysis and continuous ambulatory peritoneal dialysis: a multicenter study. Nephron Clin Pract 2014;128(3-4):352-60.

Ronco C, Amerling R, Dell’Aquila R, Rodighiero MP, Loreto PI. Evolution of technology for automated peritoneal dialysis. Contrip Nephrol 2006;150:291-309.

Yu Y, Zhou Y, Wang H, Zhou T, Li T, Wu Yan, et al. Impact of continuous quality improvement initiatives on clinical outcomes in peritoneal dialysis. Perit Dial Int 2014;34(Suppl 2);S43–S8.

Taji L, Thomas D, Oliver MJ, Ip J, Tang Y, Yeung A, et al. COVID-19 in patients undergoing long-term dialysis in Ontario. CMAJ 2021;193(8):E278-E84.

Weinhandl ED, Wetmore JB, Peng Y, Liu J, Gilbertson DT, Johansen KL. Initial effects of COVID-19 on patients with ESKD. J Am Soc Nephrol 2021;32(6):1444-53.

International Society for Peritoneal Dialysis (ISPD). Strategies regarding COVID-19 in PD patients [Internet]. 2020 [cited 2020 Apr 6]. Available: https://ispd.org/strategies-covid19/

Jorres A, Gahl GM. Nightly intermittent peritoneal dialysis: targets and prescriptions. Perit Dial Int 2000;20(Suppl 2):S89-92.

Akonur A, Guest S, Sloand JA, Leypoldt JK. Automated peritoneal dialysis prescriptions for enhancing sodium and fluid removal: a predictive analysis of optimized, patient-specific dwell times for the day period. Perit Dial Int 2013;33(6):646-54.

Sritippayawan S, Nilwarangkur S, Aiyasanon N, Jattanawanich P, Vasuvattakul S. Practical guidelines for automated peritoneal dialysis. J Med Assoc Thai 2011;94(Suppl 4): S167-S74.

Asghar RB, Davies SJ. Pathways of fluid transport and reabsorption across the peritoneal membrane. Kidney Int 2008;73(9):1048-53.

Szeto CC, Wong TY, Chow KM, Leung CB, Law MC, Wang AY, et al. Impact of dialysis adequacy on the mortality and morbidity of anuric Chinese patients receiving continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 2001;12(2):355-60.

Brown EA, Davies SJ, Rutherford P, Meeus F, Borras M, Riegel W, et al. Survival of functionally anuric patients on automated peritoneal dialysis: the European APD outcome study. JASN 2003;14(11):2948-57.

Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes-Canada-USA (CANUSA) peritoneal dialysis study group. J Am Soc Nephrol 1996;7(2):198-207.

Rocco M, Soucie JM, Pastan S, McClellan WM. Peritoneal dialysis adequacy and risk of death. Kidney Int 2000;58(1):446-57.

Genestier S, Hedelin G, Schaffer P, Faller B. Prognostic factors in CAPD patients: a retrospective study of a ten-year period. Nephrol Dial Transplant 1995;10(10):1905-11.

Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002;13(5):1307-20.

Churchill DN. The ADEMEX study: make haste slowly. J Am Soc Nephrol 2002;13(5):1415-18.

Jager KJ, Merkus MP, Decker FW, Boeschoten EW, Tijssen JG, Stevens P, et al. Mortality and technique failure in patients starting chronic peritoneal dialysis: results of the Netherlands cooperative study on the adequacy of dialysis. NECOSAD study group. Kidney Int 1999;55(4):1476-85.

Downloads

Published

2024-04-29

How to Cite

1.
Chowpontong S. Patient Survival and Factors Affecting Mortality on Automated Peritoneal Dialysis in Phra Nakhon Si Ayutthaya Hospital . JPMAT [Internet]. 2024 Apr. 29 [cited 2024 Nov. 23];14(1):189-208. Available from: https://he01.tci-thaijo.org/index.php/JPMAT/article/view/265295

Issue

Section

Original Article